Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01631566
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
J72 | (3E)-5-fluoro-1-[(6-fluoro-4H-1,3- benzodioxin-8-yl)methyl]-1H-indole- 2,3-dione 3-oxime | X | 3G90 | 0.74 | |
771 | 4-(4-BENZYLOXY-2-METHANESULFONYLAMINO- 5-METHOXY-BENZYLAMINO)-BENZAMIDINE | H,L | 1W0Y | 0.71 | |
MSI | 1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE- 1-SULFONYL)-1H-INDOLE-2,3-DIONE | A | 1GFW | 0.74 | |
4BG | N-[4-(benzyloxy)phenyl]glycinamide | A | 3CHO | 0.73 | |
11R | RUTHENIUM WIRE, 11 CARBON LINKER | A | 2CG1 | 0.7 | |
451 | N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin- 2-yl)acetamide | A | 3FYX | 0.76 | |
L05 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)- 4-PHENYLPYRROLE-2,5-DIONE | A,B,C,D,E,F, G,H | 2ACL | 0.71 | |
4BQ | (2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid | A | 3CHQ | 0.73 | |
J67 | (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin- 8-yl)methyl]-4-[(E)-2-phenylethenyl]- 1H-indole-2,3-dione 3-oxime | X | 3G9L | 0.73 | |
RPF | 1-{4-[3-(2-METHOXY-BENZYLOXY)-PROPOXY]- PHENYL}-6-(1,2,,3,4-TETRAHYDRO- QUINOLIN-7-YLOXYMETHYL)-PIPERAZIN- 2-ONE | A,B | 2BKT | 0.74 | |
RXD | N-[3-(2-fluoroethoxy)phenyl]-N'- (1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin- 6-yl)butanediamide | A,B,C,D | 3DEK | 0.72 | |
PZD | (11aS)-7,8-dimethoxy-2-naphthalen- 2-yl-1,10,11,11a-tetrahydro-5H- pyrrolo[2,1-c][1,4]benzodiazepin- 5-one | A,B | 2K4L | 0.7 | |
GVB | (3R,4S)-1-(3,4-DIMETHOXYPHENYL)- 3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE | A,B | 2JID | 0.78 | |
XM5 | 6-methoxy-9-methyl[1,3]dioxolo[4,5- h]quinolin-8(9H)-one | A,B | 3G5M | 0.7 | |
MDC | N-[2-(1-MALEIMIDYL)ETHYL]-7-DIETHYLAMINOCOUMARIN- 3-CARBOXAMIDE | A | 1A54 | 0.75 | |
1CD | (13R,15S)-13-METHYL-16-OXA-8,9,12,22,24- PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA- 1(24),2,4,6,17(25),18,20-HEPTAENE- 23,26-DIONE | A | 2DS1 | 0.72 | |
4BU | (2S)-2-amino-5-[[4-[(2S)-2-hydroxy- 2-phenyl-ethoxy]phenyl]amino]-5- oxo-pentanoic acid | A | 3CHS | 0.73 | |
RHO | TETRAMETHYLRHODAMINE-5-MALEIMIDE | A | 1J6Z | 0.71 | |
RHO | TETRAMETHYLRHODAMINE-5-MALEIMIDE | A | 1NWK | 0.71 | |
GSG | 1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A- HEXAHYDROPYRROLO[2,3-B]INDOL-5- YL 2-ETHYLPHENYLCARBAMATE | A | 2BAG | 0.7 | |
VG4 | N-[(1S,2R)-1-benzyl-3-{[(1S)-2- (cyclohexylamino)-1-methyl-2-oxoethyl]amino}- 2-hydroxypropyl]-3-(2-oxo-2,3-dihydro- 1H-pyrrol-1-yl)-5-propoxybenzamide | A | 2VIZ | 0.7 | |
R4A | BIS[1H,1'H-2,2'-BIPYRIDINATO(2- )-KAPPA~2~N~1~,N~1'~]{3-[4-(1,10- DIHYDRO-1,10-PHENANTHROLIN-4-YL- KAPPA~2~N~1~,N~10~)BUTOXY]-N,N- DIMETHYLANILINATO(2-)}RUTHENIUM | A,B | 2CFD | 0.7 | |
R4A | BIS[1H,1'H-2,2'-BIPYRIDINATO(2- )-KAPPA~2~N~1~,N~1'~]{3-[4-(1,10- DIHYDRO-1,10-PHENANTHROLIN-4-YL- KAPPA~2~N~1~,N~10~)BUTOXY]-N,N- DIMETHYLANILINATO(2-)}RUTHENIUM | A,B | 2CFG | 0.7 | |
R4A | BIS[1H,1'H-2,2'-BIPYRIDINATO(2- )-KAPPA~2~N~1~,N~1'~]{3-[4-(1,10- DIHYDRO-1,10-PHENANTHROLIN-4-YL- KAPPA~2~N~1~,N~10~)BUTOXY]-N,N- DIMETHYLANILINATO(2-)}RUTHENIUM | A | 2BT3 | 0.7 | |
J88 | (3Z)-1-[(6-fluoro-4H-1,3-benzodioxin- 8-yl)methyl]-4-phenyl-1H-indole- 2,3-dione 3-oxime | A | 3G9N | 0.73 | |
ROS | N,N'-TETRAMETHYL-ROSAMINE | A | 1F1T | 0.7 | |
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.76 | |
4BO | (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid | A | 3CHP | 0.74 |